Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group-Reference-Cited by-同舟云学术

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Ettrich Thomas J.^ORCID,Berger Andreas W.,Perkhofer Lukas,Daum Severin,König Alexander,Dickhut Andreas,Wittel Uwe,Wille Kai,Geissler Michael,Algül Hana,Gallmeier Eike,Atzpodien Jens,Kornmann Marko,Muche Rainer,Prasnikar Nicole,Tannapfel Andrea,Reinacher-Schick Anke,Uhl Waldemar,Seufferlein Thomas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5183-y.pdf

Reference39 articles.

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.

2. Howlader N NA, Krapcho M et al: SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. SEER web site 2013.

3. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913–21.

4. Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell. 2012;148(1–2):362–75.

5. Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, et al. S3-guideline exocrine pancreatic cancer. Zeitschrift fur Gastroenterologie. 2013;51(12):1395–440.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes following pancreaticoduodenectomy for octogenarians: a systematic review and meta-analysis;HPB;2024-08

2. Multimodal Approaches to Patient Selection for Pancreas Cancer Surgery;Current Oncology;2024-04-15

3. Failure of a Multi-Centric Clinical Trial Investigating Neoadjuvant Radio-Chemotherapy in Resectable Pancreatic Carcinoma (NEOPA-NCT01900327)—Which Lessons Are Learnt?;Cancers;2023-08-25

4. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives;Critical Reviews in Oncology/Hematology;2023-06

5. Role of neoadjuvant treatment in resectable pancreatic cancer according to vessel invasion and increase of CA19‐9 levels;Journal of Hepato-Biliary-Pancreatic Sciences;2023-03-13